RecruitingNCT06951984

Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease

Hydroxyephedrine PET/CT in Sympathetic Nervous System Diseases

Sponsor

Tianjin Medical University

Enrollment

500 participants

Start Date

Mar 1, 2013

Study Type

OBSERVATIONAL

Conditions

Sympathetic Nervous System Diseases Sympathetic Nervous Structure Injury Sympathetic Nerve Injury

Summary

To evaluate the potential usefulness of 11C/18F-HED positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 11C/18F-HED for people with sympathetic nerve injury, sympathetic nervous structure injury, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TEST11C/18F-HED

Each subject receive a single intravenous injection of 11C/18F-HED and undergo PET/CT or MRI imaging within the specificed time.

Locations(1)

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06951984

Related Trials

Sympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease

NCT048498061 location